PRN
vs
S&P TSX Composite Index (Canada)

Over the past 12 months, PRN has underperformed S&P TSX Composite Index (Canada), delivering a return of -31% compared to the S&P TSX Composite Index (Canada)'s 6% growth.
Stocks Performance
PRN vs S&P TSX Composite Index (Canada)
Performance Gap
PRN vs S&P TSX Composite Index (Canada)
Performance By Year
PRN vs S&P TSX Composite Index (Canada)
Profound Medical Corp
Glance View
Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. The company is headquartered in Mississauga, Ontario and currently employs 146 full-time employees. The company went IPO on 2014-09-24. The firm is commercializing TULSA-PRO, which is a technology that combines real-time magnetic resonance imaging (MRI), transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum to help preserve the patient’s natural functional abilities. The firm is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
